Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 136 No. 2122 (2006)

Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland

  • AJ Palmer
  • S Roze
  • WJ Valentine
  • JA Ray
DOI
https://doi.org/10.57187/smw.2006.11337
Cite this as:
Swiss Med Wkly. 2006;136:346-346
Published
27.05.2006